Based in Granada, Spain, and with a staff of more than 150, Biosearch Life is active in the nutraceutical and functional food sectors. The company has a range of probiotics including in premium probiotics obtained from human breast milk (the Hereditum brand), scientifically backed botanical extracts (Exxentia) and natural omega-3 (the Eupoly-3 brand).
The acquisition is envisaged to be completed by means of a friendly public tender offer for the shares of Biosearch Life addressed to all of its shareholders, and is subject to the prior approval of the Spanish National Securities Markets Commission and, upon its approval, to the acceptance of the offer by Biosearch Life's shareholders.
Grupo Lactalis Iberia, S.A., main shareholder of Biosearch Life, has irrevocably undertaken to tender its entire stake representing 29.5% of the share capital of the company into the offer.